Brokerages Set Vitalhub Corp. (TSE:VHI) Price Target at C$12.08

Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have been given a consensus rating of "Buy" by the five ratings firms that are covering the company, Marketbeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in the last year is C$12.08.

Several analysts recently commented on the stock. Canaccord Genuity Group raised their price target on shares of Vitalhub from C$12.00 to C$12.50 and gave the company a "buy" rating in a research report on Thursday, January 16th. Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, January 30th. TD Securities lifted their price target on Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. Finally, Raymond James set a C$13.50 price target on Vitalhub and gave the stock an "outperform" rating in a research report on Thursday, March 27th.

Vitalhub Trading Up 1.7 %

Vitalhub stock traded up C$0.17 during mid-day trading on Monday, hitting C$10.07. The company had a trading volume of 108,447 shares, compared to its average volume of 137,991. The company has a market capitalization of C$544.71 million, a price-to-earnings ratio of 163.78, a P/E/G ratio of 1.18 and a beta of 1.26. The company's fifty day moving average is C$9.78 and its 200-day moving average is C$10.46. Vitalhub has a 12-month low of C$5.99 and a 12-month high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.